TCT CONNECT-168 Calcified Coronary Lesions Treated With Intravascular Lithotripsy: 1-Year Outcomes

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: 1-Year Results From the Disrupt CAD III Study

“…with acute coronary syndromes and IVL treatment of in-stent restenosis have also reported favorable safety and effectiveness outcomes of coronary IVL with low rates of adverse clinical events at 1 year. 26,27 Thus, the relative 1-year benefits of IVL were sustained in both indirect comparisons with orbital atherectomy 28,29 and with historical cohorts of patients with moderate or severe target lesion calcification undergoing PCI with other lesion preparation techniques. 6,30,31 Nonetheless, adequately powered randomized trials are required to further evaluate the relative safety and effectiveness of different types of calcium-modifying therapies for calcified lesions.…”

“…[37][38][39] The safety and effectiveness of coronary IVL as an adjunct to stenting has been observed by others in smaller, initial "real-world" clinical experiences with limited 1-year follow-up. 26,27 Additionally,…”

Intravascular Lithotripsy for Vessel Preparation in Calcified Coronary Arteries Prior to Stent Placement ― Japanese Disrupt CAD IV Study 1-Year Results ―

“…[14][15][16] The results presented here are novel because they represent the first long-term data with coronary IVL in Asian patients. Wong et al 24 were the first group to report 1-year outcomes with coronary IVL. Among 44 patients treated at a single center in Australia, there were no procedural complications, no reports of Q wave MI or cardiovascular death through 1 year, and a TLR rate of 6.8%.…”

Shock Wave Intravascular Lithotripsy: Shock the Rock

“…Data describing IVL in the setting of ACS have also been described in a small number of patients. [37][38][39][40][41] Wong et al reported real world data in patients treated with IVL (n = 44). In this registry 57% of patients had ACS at presentation.…”